NASDAQ:BBIO

Bridgebio Pharma Stock Insider Trading

etoro logo Buy BBIO
*Your capital is at risk
$65.48
+1.60 (+2.50%)
At Close: Jun 03, 2026

Bridgebio Pharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -80.57. In total, the insiders bought 728.07K and sold 624.83K BBIO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-80.57
Buy 728.07K shares
Sell 624.83K shares
28% Buy Activity
Moderate Negative Correlation
Buy Signal Low Confidence
Mar 18, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -80.57.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
May 08, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 5 076
Value: $341.8K
May 08, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 950
Value: $64.9K
May 08, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 13 973
Value: $931.3K
May 08, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 5 077
Value: $341.9K
May 08, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 950
Value: $64.9K
May 07, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 11 217
Value: $757.1K
May 07, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 8 333
Value: $569.8K
May 07, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 450
Value: $31.1K
May 07, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 449
Value: $31.0K
May 07, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 8 334
Value: $569.9K
May 07, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 11 217
Value: $757.1K
Apr 30, 2026
Sell
Common Stock
S-Sale
Apuli Maricel
Chief Accounting Officer
Officer 2 000
Value: $143.2K
Apr 10, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 20 000
Value: $1.49M
Apr 10, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 20 000
Value: $1.49M
Apr 09, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 7 500
Value: $566.7K
Apr 09, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 7 072
Value: $520.8K
Apr 09, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 5 300
Value: $395.4K
Apr 09, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 7 200
Value: $530.2K
Apr 09, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 7 800
Value: $589.1K
Apr 09, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 5 128
Value: $382.4K
Mar 18, 2026
Buy
Common Stock
A-Award
Apuli Maricel
Chief Accounting Officer
Officer 14 170
Value: $993.6K
Mar 18, 2026
Buy
Common Stock
A-Award
Trimarchi Thomas
President And CFO
CEO / President 59 041
Value: $4.14M
Mar 17, 2026
Buy
Stock Option (Right to Buy)
A-Award
Kumar Neil
Chief Executive Officer
CEO / President 40 570
Value: $2.88M
Mar 17, 2026
Buy
Restricted Stock Units
A-Award
Kumar Neil
Chief Executive Officer
CEO / President 104 313
Value: $7.40M
Mar 13, 2026
Sell
Common Stock
S-Sale
Kumar Neil
Chief Executive Officer
CEO / President 10 241
Value: $700.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT BRIDGEBIO PHARMA INC.
Bridgebio Pharma
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabilizer of transthyretin, or TTR that is in Phase 3 clinical trial for the treatment of TTR amyloidosis-car...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE